How Long Do You Stay on Mounjaro or Tirzepatide?

There is no standard course of Mounjaro that everyone should take for weight loss. The appropriate duration depends on why a medicine was prescribed, its benefits and side effects, and the ongoing plan agreed with the prescriber. Reaching a target weight is a reason to review that plan, not automatically a reason to stop.

Mounjaro and Zepbound are different branded medicines

Both contain tirzepatide, but their approved uses differ. The current Mounjaro prescribing information includes type 2 diabetes and specified cardiovascular-risk reduction in adults with type 2 diabetes. Mounjaro is not the tirzepatide brand approved for chronic weight management.

Zepbound prescribing information includes long-term weight reduction and maintenance in eligible adults, alongside diet and activity changes. Discuss which product is being considered, its indication, and whether any proposed use is off-label. A compounded formulation is not the same product as either brand.

Does “72 weeks” mean treatment should end then?

No. Seventy-two weeks was the study duration in SURMOUNT-1, a clinical trial of tirzepatide in adults with obesity or overweight with a weight-related complication, excluding diabetes. A research study's endpoint is not a prescription for how long every patient should remain on treatment.

Medication may be part of a longer-term plan when benefits continue to outweigh risks. NIDDK explains that weight-management medication duration depends on response, tolerability, and clinical judgment. Your follow-up plan should be specific to you.

What happens after stopping?

Weight regain can occur after stopping treatment. In SURMOUNT-4, adults who switched from tirzepatide to placebo regained substantial weight on average, while those who continued maintained and extended their earlier reduction. This trial supports planning for maintenance; it does not predict an individual's result or mean everyone must remain on the same medicine indefinitely.

If cost, side effects, access, or pregnancy plans make a change necessary, discuss that change with the prescriber. Do not alter dosing or restart after an interruption based on an online schedule.

What should a follow-up discussion cover?

• The reason for treatment and whether the intended health benefits are occurring.
• Side effects, eating and drinking, and any new health conditions or medicines.
• How response will be monitored and when the next review is due.
• The full ongoing cost, including medication and appointments.
• A plan for interruptions, stopping, or switching treatment if needed.

Tirzepatide products have important warnings and contraindications, including a boxed warning about thyroid C-cell tumors observed in rats. They are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. Review the complete product label and your history with the prescriber; this article is not a dosing guide.

Discuss your options at Atlanta Medical Institute

Explore our tirzepatide consultation information and Mounjaro questions. The initial consultation is $125, prepaid to reserve an appointment. Medication, testing, and continuing care costs are discussed separately. A consultation does not guarantee prescribing or coverage.

Call (404) 264-9553 or contact our team. We are at 5009 Roswell Road NE, Suite 201, Sandy Springs, GA 30342.